Table 2.
Drugs associated with melanocytic activation and subsequent longitudinal melanonychia. Table adapted from J. Andre, N. Lateur. Pigmented nail disorders [2].
| Drug-induced melanonychia | |
|---|---|
| Chemotherapeuticals | Others |
|
| |
| Bleomycin sulfate | ACTH |
| Busulfan | Amodiaquine |
| Cyclophosphamide | Amorolfine |
| Dacarbazine | Arsenic |
| Daunorubicin hydrochloride | Chloroquine |
| Doxorubicin | Clofazimine |
| Etoposide | Clomipramine |
| 5-fluorouracile | Cyclones |
| Hydroxyurea | Fluconazole |
| Imatinib | Fluorides |
| Melphalan hydrochloride | Gold salts |
| Methotrexate | Ibuprofen |
| Nitrogen mustard | Ketoconazole |
| Nitrosourea | Lamivudine |
| Tegafur | Mepacrine |
| Mercury | |
| MSH | |
| Minocycline | |
| PCB | |
| Phenytoin | |
| Phenothiazine | |
| Psoralen | |
| Roxithromycin | |
| Steroids | |
| Sulfonamide | |
| Thallium | |
| Timolol | |
| Zidovudine | |